Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pure MHC to Partner with AbbVie on Oncology Research
Tuesday, January 10, 2017Emergent Technologies Inc ETI announced that its target discovery portfolio company Pure MHC and global biopharmaceutical company AbbVie NYSEABBV will embark on a research and license agreement to discover and validate peptide targets for use with Tc...
Takeda to Acquire ARIAD Pharmaceuticals, Inc. for $5.2 Billion
Tuesday, January 10, 2017Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals Inc announced that they have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for per share in cash or an enterprise value of a...
Zebra Biologics Inc. to Collaborate with AbbVie to Discover New Antibody Therapeutics
Tuesday, January 10, 2017Zebra Biologics Inc an emerging preclinical stage biotechnology company announced that the company has entered into a collaboration with AbbVie to discover agonist antibody therapeutics for inflammatory diseases Zebra will use its novel and patented...
Enzyvant to Develop Novel Biologic Therapy for Complete DiGeorge Syndrome
Monday, January 09, 2017Enzyvant a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases today announced entering into an exclusive worldwide licensing agreement with Duke University to develop RVT a tissuebased therapy for th...
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Monday, January 09, 2017Ipsen today announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals including its key marketed product ONIVYDE irinotecan liposome injection for the treatment of patients with metasta...
Mast Therapeutics And Savara Sign Merger Agreement
Saturday, January 07, 2017Mast Therapeutics Inc and Savara Inc a privatelyheld emerging specialty pharmaceutical company focused on the treatment of rare respiratory diseases today announced that the two companies have entered into a definitive merger agreement under which th...
Takeda Pharmaceutical and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease
Friday, January 06, 2017Takeda Pharmaceutical Company Limited and PvP Biologics Inc announced a global agreement for the development of KumaMax a novel enzyme designed to break down the immunereactive parts of gluten in the stomach thereby avoiding the painful symptoms and...
PTC Therapeutics Announces Initiation of FIREFISH Study in Infant (Type I) SMA Patients
Friday, January 06, 2017PTC Therapeutics Inc announced that its joint development program in Spinal Muscular Atrophy SMA with Roche and the SMA Foundation SMAF initiated a clinical study in infants with Type I SMA The study named FIREFISH will investigate the safety tolerab...
Ambrx and MabSpace Biosciences to Collaborate on Novel Antibody Drug Conjugates
Friday, January 06, 2017San Diego based Ambrx Inc and Suzhou based MabSpace Biosciences have agreed to collaborate on discovery and development of multiple novel ADCs in China and around the world for oncology According to the agreement MabSpace will employ its proprietary...
Senhwa Biosciences CX-4945 Granted Orphan Drug Designation by the US FDA
Thursday, January 05, 2017Senhwa Biosciences Inc announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to CX for the treatment of cholangiocarcinoma CX is a novel small molecule drug that inhibits protein kinase CK which plays an importan...
